Catalyst Pharmaceuticals (NASDAQ:CPRX) reported quarterly earnings of $0.14 per share which beat the analyst consensus estimate of $0.10 by 40 percent. This is a 7.69 percent increase over earnings of $0.13 per share from the same period last year. The company reported quarterly sales of $35.90 million which beat the analyst consensus estimate of $34.59 million by 3.79 percent. This is a 22.45 percent increase over sales of $29.32 million the same period last year.
Catalyst Pharmaceuticals Q3 Adj. EPS $0.14 Beats $0.10 Estimate, Sales $35.90M Beat $34.59M Estimate
Catalyst Pharmaceuticals (NASDAQ:CPRX) reported quarterly earnings of $0.14 per share which beat the analyst consensus estimate of $0.10 by 40 percent. This is a 7.69 percent increase over earnings of $0.13 per share
